Cancer BiologybioRxivPreprint
RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenografts
M. Ciscar, E. M. Trinidad, H. Perez-Montoyo…·E. Gonzalez-Suarez
This study shows RANK is a poor prognosis biomarker in ER-negative breast cancer and that targeting RANK improves outcomes in patient-derived xenografts.
DOI 10.1101/2021.12.13.470911